-
公开(公告)号:US20110243932A1
公开(公告)日:2011-10-06
申请号:US13075303
申请日:2011-03-30
申请人: Rachel Rebecca BARRETT , Scott Ronald BRODEUR , Keith CANADA , Tobias LITZENBURGER , Sanjaya SINGH
发明人: Rachel Rebecca BARRETT , Scott Ronald BRODEUR , Keith CANADA , Tobias LITZENBURGER , Sanjaya SINGH
CPC分类号: C07K16/2878 , A61K9/0019 , A61K2039/505 , C07K1/22 , C07K2317/24 , C07K2317/33 , C07K2317/51 , C07K2317/515 , C07K2317/53 , C07K2317/565 , C07K2317/71 , C07K2317/73 , C07K2317/732 , C07K2317/76 , C07K2317/92 , C07K2317/94
摘要: The present invention relates to new humanized antagonistic anti-CD40 antibodies and therapeutic and diagnostic methods and compositions for using the same.
摘要翻译: 本发明涉及新的人源化拮抗性抗CD40抗体及其使用的治疗和诊断方法及组合物。
-
公开(公告)号:US08591900B2
公开(公告)日:2013-11-26
申请号:US13075303
申请日:2011-03-30
申请人: Rachel Rebecca Barrett , Scott Ronald Brodeur , Keith Canada , Tobias Litzenburger , Sanjaya Singh
发明人: Rachel Rebecca Barrett , Scott Ronald Brodeur , Keith Canada , Tobias Litzenburger , Sanjaya Singh
IPC分类号: A61K39/395 , C07K16/28
CPC分类号: C07K16/2878 , A61K9/0019 , A61K2039/505 , C07K1/22 , C07K2317/24 , C07K2317/33 , C07K2317/51 , C07K2317/515 , C07K2317/53 , C07K2317/565 , C07K2317/71 , C07K2317/73 , C07K2317/732 , C07K2317/76 , C07K2317/92 , C07K2317/94
摘要: The present invention relates to new humanized antagonistic anti-CD40 antibodies and therapeutic and diagnostic methods and compositions for using the same.
摘要翻译: 本发明涉及新的人源化拮抗性抗CD40抗体及其使用的治疗和诊断方法及组合物。
-
3.Effectors of PAR-2 Activation and Their Use in the Modulation of Inflammation 审中-公开
标题翻译: PAR-2激活的作用及其在炎症调节中的应用公开(公告)号:US20110311553A1
公开(公告)日:2011-12-22
申请号:US13160758
申请日:2011-06-15
申请人: Tobias LITZENBURGER , Sandra MILLER , Catrin PRACHT , Rainer BOXHAMMER , Jeanne MAGRAM , Patricia GIBLIN , Daniel RAJOTTE
发明人: Tobias LITZENBURGER , Sandra MILLER , Catrin PRACHT , Rainer BOXHAMMER , Jeanne MAGRAM , Patricia GIBLIN , Daniel RAJOTTE
IPC分类号: A61K39/395 , A61P29/00 , A61P11/06 , A61P19/02 , A61P17/00 , A61P1/00 , C07K16/28 , A61P17/06
CPC分类号: C07K16/28 , A61K2039/505 , C07K2317/34 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/92
摘要: The present invention relates to the recognition that PAR-2 receptors amplify the inflammatory response and that effectors of PAR-2 activation can thus be used to modulate the inflammatory response and thereby impart therapeutic benefit to patients. The invention is particularly directed to the use of PAR-2 effectors in the treatment of inflammation and nociception (pain) caused by inflammation, cancer and injury. The invention is particularly directed to negative effectors of PAR-2 activation, and more particularly to anti-PAR-2 antibodies that are negative effectors of PAR-2 activation.
摘要翻译: 本发明涉及PAR-2受体扩增炎症反应的认识,因此PAR-2活化的作用者可用于调节炎症反应,从而赋予患者治疗益处。 本发明特别涉及使用PAR-2效应物治疗由炎症,癌症和损伤引起的炎症和伤害感受(疼痛)。 本发明特别涉及PAR-2活化的负效应物,更特别地涉及作为PAR-2活化的负效应物的抗PAR-2抗体。
-
公开(公告)号:US20140377265A1
公开(公告)日:2014-12-25
申请号:US14337357
申请日:2014-07-22
申请人: Joanne VAN RYN , Keith CANADA , Robert COPENHAVER , Norbert HAUEL , Tobias LITZENBURGER , Christopher Ronald SARKO , Sanjaya SINGH , Alisa K. WATERMAN
发明人: Joanne VAN RYN , Keith CANADA , Robert COPENHAVER , Norbert HAUEL , Tobias LITZENBURGER , Christopher Ronald SARKO , Sanjaya SINGH , Alisa K. WATERMAN
IPC分类号: C07K16/44 , A61K31/4439 , A61K39/395
CPC分类号: C07K16/44 , A61K31/4439 , A61K39/395 , A61K39/39583 , A61K2039/505 , C07K2299/00 , C07K2317/14 , C07K2317/21 , C07K2317/24 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/92 , A61K2300/00
摘要: The present invention relates to antibody molecules against anticoagulants, in particular dabigatran, and their use as antidotes of such anticoagulants.
摘要翻译: 本发明涉及针对抗凝剂,特别是达比加群的抗体分子,以及它们作为这种抗凝剂的解毒剂的用途。
-
5.Anticoagulant antidotes comprising antibodies that bind dabigatran and/or related compounds and methods of use thereof 有权
标题翻译: 抗凝血剂解毒剂,其包含结合达比加群和/或相关化合物的抗体及其使用方法公开(公告)号:US08821871B2
公开(公告)日:2014-09-02
申请号:US13432296
申请日:2012-03-28
申请人: Joanne Van Ryn , Keith Canada , Robert Copenhaver , Norbert Hauel , Tobias Litzenburger , Christopher Ronald Sarko , Sanjaya Singh , Alisa K. Waterman
发明人: Joanne Van Ryn , Keith Canada , Robert Copenhaver , Norbert Hauel , Tobias Litzenburger , Christopher Ronald Sarko , Sanjaya Singh , Alisa K. Waterman
IPC分类号: A61K39/395 , C07K16/44
CPC分类号: C07K16/44 , A61K31/4439 , A61K39/395 , A61K39/39583 , A61K2039/505 , C07K2299/00 , C07K2317/14 , C07K2317/21 , C07K2317/24 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/92 , A61K2300/00
摘要: The present invention relates to antibody molecules against anticoagulants, in particular dabigatran, and their use as antidotes of such anticoagulants.
摘要翻译: 本发明涉及针对抗凝剂,特别是达比加群的抗体分子,以及它们作为这种抗凝剂的解毒剂的用途。
-
公开(公告)号:US20140179907A1
公开(公告)日:2014-06-26
申请号:US14046121
申请日:2013-10-04
申请人: Rachel Rebecca BARRETT , Scott Ronald BRODEUR , Keith CANADA , Tobias LITZENBURGER , Sanjaya SINGH
发明人: Rachel Rebecca BARRETT , Scott Ronald BRODEUR , Keith CANADA , Tobias LITZENBURGER , Sanjaya SINGH
IPC分类号: C07K16/28
CPC分类号: C07K16/2878 , A61K9/0019 , A61K2039/505 , C07K1/22 , C07K2317/24 , C07K2317/33 , C07K2317/51 , C07K2317/515 , C07K2317/53 , C07K2317/565 , C07K2317/71 , C07K2317/73 , C07K2317/732 , C07K2317/76 , C07K2317/92 , C07K2317/94
摘要: The present invention relates to new humanized antagonistic anti-CD40 antibodies and therapeutic and diagnostic methods and compositions for using the same.
摘要翻译: 本发明涉及新的人源化拮抗性抗-CD40抗体以及使用该抗CD40抗体的治疗和诊断方法和组合物。
-
公开(公告)号:US20120114659A1
公开(公告)日:2012-05-10
申请号:US13132493
申请日:2009-11-17
IPC分类号: A61K39/395 , C12N15/13 , A61P9/04 , A61P9/12 , A61P9/10 , A61P13/12 , A61P25/00 , A61P9/00 , A61P9/06 , A61P7/02 , A61P3/00 , A61P37/08 , A61P3/10 , A61P11/06 , A61P29/00 , A61P3/04 , A61P35/00 , C12N15/63 , C12N5/10 , C12N1/21 , C12N1/19 , C12N1/15 , C12P21/00 , C12N9/96 , A61P7/10 , C07K16/40
CPC分类号: C07K16/2869 , C07K2317/24 , C07K2317/34 , C07K2317/35 , C07K2317/55 , C07K2317/75 , C07K2317/92 , C07K2319/30
摘要: Monoclonal antibodies that act as potentiators, stimulators and agonists of guanylyl cyclase receptors are disclosed.
摘要翻译: 公开了作为鸟苷酸环化酶受体的增强剂,刺激剂和激动剂的单克隆抗体。
-
公开(公告)号:US09499633B2
公开(公告)日:2016-11-22
申请号:US14521499
申请日:2014-10-23
IPC分类号: A61K39/395 , C07K16/44
CPC分类号: C07K16/44 , C07K2299/00 , C07K2317/24 , C07K2317/55 , C07K2317/565 , C07K2317/76 , C07K2317/92
摘要: The present invention relates to antibody molecules against anticoagulants, in particular dabigatran, and their use as antidotes of such anticoagulants.
摘要翻译: 本发明涉及针对抗凝剂,特别是达比加群的抗体分子,以及它们作为这种抗凝剂的解毒剂的用途。
-
公开(公告)号:US09090696B2
公开(公告)日:2015-07-28
申请号:US14046121
申请日:2013-10-04
申请人: Rachel Rebecca Barrett , Scott Ronald Brodeur , Keith Canada , Tobias Litzenburger , Sanjaya Singh
发明人: Rachel Rebecca Barrett , Scott Ronald Brodeur , Keith Canada , Tobias Litzenburger , Sanjaya Singh
CPC分类号: C07K16/2878 , A61K9/0019 , A61K2039/505 , C07K1/22 , C07K2317/24 , C07K2317/33 , C07K2317/51 , C07K2317/515 , C07K2317/53 , C07K2317/565 , C07K2317/71 , C07K2317/73 , C07K2317/732 , C07K2317/76 , C07K2317/92 , C07K2317/94
摘要: The present invention relates to new humanized antagonistic anti-CD40 antibodies and therapeutic and diagnostic methods and compositions for using the same.
摘要翻译: 本发明涉及新的人源化拮抗性抗CD40抗体及其使用的治疗和诊断方法及组合物。
-
10.Methods of using antibodies during anticoagulant therapy of dabigatran and/or related compounds 有权
标题翻译: 在达比加群和/或相关化合物的抗凝治疗期间使用抗体的方法公开(公告)号:US09034822B2
公开(公告)日:2015-05-19
申请号:US13916994
申请日:2013-06-13
申请人: Joanne Van Ryn , John Edward Park , Norbert Hauel , Ulrich Kunz , Tobias Litzenburger , Keith Canada , Sanjaya Singh , Alisa Waterman
发明人: Joanne Van Ryn , John Edward Park , Norbert Hauel , Ulrich Kunz , Tobias Litzenburger , Keith Canada , Sanjaya Singh , Alisa Waterman
IPC分类号: A61K39/395 , C07K16/44
CPC分类号: C07K16/44 , A61K31/4439 , A61K39/39583 , C07K2317/24 , C07K2317/54 , C07K2317/55 , C07K2317/565 , C07K2317/569 , C07K2317/622 , C07K2317/626 , C07K2317/76 , G01N33/86 , G01N2500/02 , G01N2500/10
摘要: The present invention relates to antibody molecules against anticoagulants, in particular dabigatran, and their use as antidotes of such anticoagulants.
摘要翻译: 本发明涉及针对抗凝剂,特别是达比加群的抗体分子,以及它们作为这种抗凝剂的解毒剂的用途。
-
-
-
-
-
-
-
-
-